谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Data from First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma

Jennifer A. Woyach,Deborah M. Stephens,Ian W. Flinn,Seema A. Bhat,Ronald E. Savage,Feng Chai,Sudharshan Eathiraj,Sean D. Reiff,Elizabeth M. Muhowski,Lindsey Granlund,Lyndsey Szuszkiewicz,Wayne Wang,Brian Schwartz,Razi Ghori,Mohammed Z. H. Farooqui,John C. Byrd

CANCER DISCOVERY（2024）

引用 0|浏览31
暂无评分
关键词
BTK Inhibitors,Ibrutinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要